Allergy biotech hauls in $80M for its oral immunotherapy

Damian Garde

Food upstart Allergen Research Corporation raised an $ 80 million B round to get its lead candidate into late-stage development, pushing ahead with a treatment for peanut allergies.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS